Ad is loading...
PAMCX
Price
$103.77
Change
-$2.05 (-1.94%)
Updated
Nov 15 closing price
TRMNX
Price
$21.35
Change
-$0.29 (-1.34%)
Updated
Nov 15 closing price
Ad is loading...

PAMCX vs TRMNX

Header iconPAMCX vs TRMNX Comparison
Open Charts PAMCX vs TRMNXBanner chart's image
T. Rowe Price Mid-Cap Growth Adv
Price$103.77
Change-$2.05 (-1.94%)
VolumeN/A
CapitalizationN/A
T. Rowe Price Mid-Cap Index
Price$21.35
Change-$0.29 (-1.34%)
VolumeN/A
CapitalizationN/A
PAMCX vs TRMNX Comparison Chart
Loading...
View a ticker or compare two or three
VS
PAMCX vs. TRMNX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PAMCX is a StrongSell and TRMNX is a Buy.

FUNDAMENTALS
Fundamentals
PAMCX has more cash in the bank: 31B vs. TRMNX (231M). TRMNX pays higher dividends than PAMCX: TRMNX (0.70) vs PAMCX (0.00). PAMCX was incepted earlier than TRMNX: PAMCX (25 years) vs TRMNX (9 years). TRMNX is a more actively managed with annual turnover of: 29.50 vs. PAMCX (21.70). PAMCX (2500) and TRMNX (2500) have matching initial minimum investment requirements. TRMNX annual gain was more profitable for investors over the last year : 36.90 vs. PAMCX (13.67). TRMNX return over 5 years is better than : 60.54 vs. PAMCX (11.07).
PAMCXTRMNXPAMCX / TRMNX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence25 years9 years-
Gain YTD9.22020.96344%
Front LoadN/AN/A-
Min. Initial Investment25002500100%
Min. Initial Investment IRAN/AN/A-
Net Assets31B231M13,420%
Annual Yield % from dividends0.000.70-
Returns for 1 year13.6736.9037%
Returns for 3 years-19.72-0.662,970%
Returns for 5 years11.0760.5418%
Returns for 10 years31.11N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
HRB60.080.94
+1.59%
H&R Block
DE398.954.31
+1.09%
Deere & Company
GNE15.790.02
+0.13%
GENIE ENERGY Ltd
CMRE14.39-0.16
-1.10%
Costamare
SPRO1.18-0.07
-5.60%
Spero Therapeutics